PubRank

J Krieger

Author PubWeight™ 105.01‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The obesity-hypoventilation syndrome revisited: a prospective study of 34 consecutive cases. Chest 2001 3.60
2 Different TBX5 interactions in heart and limb defined by Holt-Oram syndrome mutations. Proc Natl Acad Sci U S A 1999 2.70
3 Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection. J Infect Dis 2001 2.63
4 In vivo migration and function of transferred HIV-1-specific cytotoxic T cells. Nat Med 1999 2.58
5 Pulmonary hemodynamics in the obstructive sleep apnea syndrome. Results in 220 consecutive patients. Chest 1996 2.53
6 Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency. J Infect Dis 1997 2.02
7 Endosymbiotic sulphate-reducing and sulphide-oxidizing bacteria in an oligochaete worm. Nature 2001 1.93
8 Two classes of olfactory receptors in Xenopus laevis. Neuron 1995 1.77
9 Effective compliance during the first 3 months of continuous positive airway pressure. A European prospective study of 121 patients. Am J Respir Crit Care Med 1999 1.73
10 Cloning and expression of odorant receptors. Nature 1993 1.68
11 Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDS. J Infect Dis 2001 1.58
12 REM sleep behavior disorder: clinical and physiopathological findings. Sleep Med Rev 1997 1.57
13 Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: implications for timing of antiretroviral therapy. J Infect Dis 2000 1.51
14 Urinary tract infection in adults: research priorities and strategies. Int J Antimicrob Agents 2001 1.51
15 Revisiting the specificity of Mamestra brassicae and Antheraea polyphemus pheromone-binding proteins with a fluorescence binding assay. J Biol Chem 2001 1.44
16 Association of chronic obstructive pulmonary disease and sleep apnea syndrome. Am J Respir Crit Care Med 1995 1.40
17 Upper airway collapsibility and cephalometric variables in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2000 1.39
18 25-Hydroxyvitamin D in Canadian adults: biological, environmental, and behavioral correlates. Osteoporos Int 2010 1.34
19 Antennal SNMPs (sensory neuron membrane proteins) of Lepidoptera define a unique family of invertebrate CD36-like proteins. J Neurobiol 2001 1.25
20 Pharyngeal critical pressure in patients with obstructive sleep apnea syndrome. Clinical implications. Am J Respir Crit Care Med 1999 1.24
21 Expression of an olfactory receptor in Escherichia coli: purification, reconstitution, and ligand binding. Biochemistry 1996 1.23
22 Three pheromone-binding proteins in olfactory sensilla of the two silkmoth species Antheraea polyphemus and Antheraea pernyi. Eur J Biochem 2000 1.20
23 Nocturnal evolution of respiratory effort in obstructive sleep apnoea syndrome: influence on arousal threshold. Eur Respir J 1998 1.14
24 Pulmonary hypertension in the obstructive sleep apnoea syndrome: prevalence, causes and therapeutic consequences. Eur Respir J 1996 1.08
25 T cell receptor antagonism mediated by interaction between T cell receptor junctional residues and peptide antigen analogues. J Immunol 1993 1.08
26 Motor proficiency in dyslexic children with and without attentional disorders. Arch Neurol 1985 1.07
27 hCG-Leydig cell functional binding kinetics: threshold and nonlinearity in response. Am J Physiol 1980 1.07
28 Signal recognition and transduction in olfactory neurons. Biochim Biophys Acta 1994 1.06
29 Molecular cloning of an insect pheromone-binding protein. FEBS Lett 1989 1.06
30 Dangerous hypoxaemia during continuous positive airway pressure treatment of obstructive sleep apnoea. Lancet 1983 1.05
31 The renal origin of sodium valproate-induced hyperammonemia in fasting humans. Neurology 1983 1.05
32 Daytime pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am Rev Respir Dis 1988 1.03
33 Expression of odorant receptors in spatially restricted subsets of chemosensory neurones. Neuroreport 1992 1.02
34 Determinants of effective continuous positive airway pressure in obstructive sleep apnea. Role of respiratory effort. Am J Respir Crit Care Med 1995 1.02
35 Cost-effectiveness of combined outreach for the pneumococcal and influenza vaccines. Arch Intern Med 2001 1.01
36 Daytime sleepiness after long-term continuous positive airway pressure (CPAP) treatment in obstructive sleep apnea syndrome. J Neurol Sci 1992 1.00
37 [18F] FDG-PET/CT as a new and sensitive imaging method for the diagnosis of large vessel vasculitis. Clin Exp Rheumatol 2008 1.00
38 Identity and expression pattern of chemosensory proteins in Heliothis virescens (Lepidoptera, Noctuidae). Insect Biochem Mol Biol 2001 0.99
39 Purification and molecular cloning of chemosensory proteins from Bombyx mori. Arch Insect Biochem Physiol 2000 0.98
40 Sodium valproate-induced hyperammonemia in the rat: role of the kidney. Eur J Pharmacol 1983 0.95
41 Cloning of biogenic amine receptors from moths (Bombyx mori and Heliothis virescens). Insect Biochem Mol Biol 1997 0.95
42 Subtypes of odorant-binding proteins--heterologous expression and ligand binding. Eur J Biochem 1998 0.93
43 The roentgenologic appearance of sclerosing cholangitis. Radiology 1970 0.93
44 Arousal threshold to respiratory stimuli in OSA patients: evidence for a sleep-dependent temporal rhythm. Sleep 1999 0.93
45 Breathing during sleep in normal young and elderly subjects: hypopneas, apneas, and correlated factors. Sleep 1983 0.93
46 Chemosensory proteins of Locusta migratoria (Orthoptera: Acrididae). Insect Biochem Mol Biol 2000 0.92
47 Cephalometric evaluation of pharyngeal obstructive factors in patients with sleep apneas syndrome. Angle Orthod 1990 0.91
48 Respiratory effort during sleep apneas after interruption of long-term CPAP treatment in patients with obstructive sleep apnea. Chest 1996 0.91
49 Primary structure of a pheromone-binding protein from Antheraea pernyi: homologies with other ligand-carrying proteins. J Comp Physiol B 1990 0.90
50 Detection and removal of an artefact fatty acid from the binding site of recombinant Bombyx mori pheromone-binding protein. Chem Senses 2001 0.90
51 Craniofacial characteristics in patients with obstructive sleep apneas syndrome. Cleft Palate J 1988 0.89
52 Transition from marine to terrestrial ecologies: changes in olfactory and tritocerebral neuropils in land-living isopods. Arthropod Struct Dev 2011 0.89
53 Cloning and expression of odorant-binding proteins Ia and Ib from mouse nasal tissue. Gene 1998 0.88
54 The expression pattern of four odorant-binding proteins in male and female silk moths, Bombyx mori. J Neurocytol 2005 0.88
55 Apnea following hyperventilation in man. J Neurol Sci 1983 0.88
56 An evaluation of bioactive ceramic in the treatment of periodontal osseous defects. Int J Periodontics Restorative Dent 1997 0.88
57 [Respiratory changes during sleep in healthy elderly subjects (author's transl)]. Rev Electroencephalogr Neurophysiol Clin 1981 0.88
58 Prognostic value of lung function and pulmonary haemodynamics in OSA patients treated with CPAP. Eur Respir J 1999 0.88
59 Auditory event-related potentials in obstructive sleep apnea: effects of treatment with nasal continuous positive airway pressure. Electroencephalogr Clin Neurophysiol 1991 0.86
60 Actigraphy and leg movements during sleep: a validation study. J Clin Neurophysiol 1999 0.86
61 Continuous positive airway pressure treatment. Effects on growth hormone, insulin and glucose profiles in obstructive sleep apnea patients. Horm Metab Res 1993 0.86
62 Obstructive sleep apnea treatment: peripheral and central effects on plasma renin activity and aldosterone. Sleep 1991 0.84
63 Effects of midazolam on sleep in normal subjects. Br J Clin Pharmacol 1983 0.84
64 [Sleep apnea synrome : effects of chlorimipramine in subjects with stable body weight (author's transl)]. Rev Electroencephalogr Neurophysiol Clin 1980 0.83
65 Medico-legal implications of sleep apnoea syndrome: driving license regulations in Europe. Sleep Med 2007 0.82
66 Weak peptide agonists reveal functional differences in B7-1 and B7-2 costimulation of human T cell clones. J Immunol 1997 0.82
67 Effects of pneumotachographic recording of breathing on sleep and respiration during sleep. Bull Eur Physiopathol Respir 1984 0.82
68 Periodic limb movements and obstructive sleep apneas before and after continuous positive airway pressure treatment. J Sleep Res 1999 0.81
69 Role of chemosensitivity in intrathoracic pressure changes during obstructive sleep apnea. Am J Respir Crit Care Med 1996 0.81
70 Respiratory effort. A factor contributing to sleep propensity in patients with obstructive sleep apnea. Chest 1996 0.81
71 Single and repeated dose kinetics of the hypnotic agent loprazolam in healthy volunteers. Eur J Clin Pharmacol 1983 0.81
72 Long-term effects of treatment with nasal continuous positive airway pressure on daytime lung function and pulmonary hemodynamics in patients with obstructive sleep apnea. Am Rev Respir Dis 1990 0.81
73 Results of a phase I study in patients suffering from secondary-progressive multiple sclerosis demonstrating the safety of the amino acid copolymer PI-2301 and a possible induction of an anti-inflammatory cytokine response. J Neuroimmunol 2010 0.80
74 Arrestin-subtypes in insect antennae. Cell Signal 1993 0.80
75 Biogenic amine metabolism in sleep apnea syndrome. Adv Biosci 1979 0.80
76 Evaluation of oral rehydration therapy in Matiguas, Nicaragua. Public Health Rep 1994 0.80
77 A marathon: the immediate effect on female runners' luteinizing hormone, follicle-stimulating hormone, prolactin, testosterone, and cortisol levels. Am J Obstet Gynecol 1983 0.79
78 Flow-volume curve abnormalities and obstructive sleep apnea syndrome. Chest 1985 0.79
79 The sensory neurone membrane protein SNMP1 contributes to the sensitivity of a pheromone detection system. Insect Mol Biol 2014 0.79
80 EMG activity of cricothyroid and chin muscles during wakefulness and sleeping in the sleep apnea syndrome. Electroencephalogr Clin Neurophysiol 1978 0.79
81 Cerebrospinal fluid adenosine 3',5'-monophosphate, 5-hydroxyindoleacetic acid and homovanillic acid in patients with sleep apnoea syndrome. J Neurol Neurosurg Psychiatry 1981 0.79
82 Breathing during sleep in normal subjects. Clin Chest Med 1985 0.79
83 Sleep apnoea syndromes in adults. Bull Eur Physiopathol Respir 1986 0.79
84 EEG spectral power and sleepiness during 24 h of sustained wakefulness in patients with obstructive sleep apnea syndrome. Clin Neurophysiol 2008 0.78
85 Frequency and mechanism of daytime pulmonary hypertension in patients with obstructive sleep apnoea syndrome. Cor Vasa 1991 0.78
86 Expression and functional analysis of olfactory receptors. Ann N Y Acad Sci 1998 0.78
87 Cyclic adenosine monophosphate signaling in the rat vomeronasal organ: role of an adenylyl cyclase type VI. Chem Senses 2000 0.77
88 Sleep-related hypoxaemia in chronic obstructive pulmonary disease: causes, consequences and treatment. Respiration 1997 0.77
89 Molecular mechanisms of olfactory signal transduction. Soc Gen Physiol Ser 1992 0.77
90 Time course of pulmonary artery pressure during sleep in sleep apnoea syndrome: role of recurrent apnoeas. Eur Respir J 1998 0.77
91 In vitro immunomodulatory activity of ruthenium complexes. Inflamm Res 2003 0.76
92 Almitrine and sleep apnea. Lancet 1982 0.76
93 Five-year effects of nasal continuous positive airway pressure in obstructive sleep apnoea syndrome. Eur Respir J 1997 0.76
94 Daytime hypoventilation in obstructive sleep apnoea syndrome. Sleep Med Rev 1999 0.76
95 Molecular cloning, sequencing and expression of cDNA encoding a G0-protein from insect. Cell Signal 1990 0.76
96 [Post-traumatic coma from diffuse brain lesions. A correlative study of the levels of dysfunction and the EEG nyctohemeral aspects (author's transl)]. Rev Electroencephalogr Neurophysiol Clin 1980 0.75
97 Apology. REM sleep behavior disorder: clinical and physiopathological findings. Sleep Med Rev 1998 0.75
98 Diurnal and nocturnal diuresis in OSA. Am Rev Respir Dis 1993 0.75
99 Chronic obstructive pulmonary disease and sleep apnea syndrome. Sleep 1992 0.75
100 [Effect of oral almitrine on the sleep apnea syndrome]. Rev Fr Mal Respir 1983 0.75
101 [Continuous positive pressure in the treatment of sleep apnea syndromes]. Presse Med 1984 0.75
102 [Respiratory arrest during sleep. Facts and hypothyses]. Rev Neurol (Paris) 1978 0.75
103 [Opsoclonia: oculographic study]. Rev Neurol (Paris) 1977 0.75
104 Matrix isolation of free radicals from carbohydrates. II. Reactions of H. with glucose and derivatives in acidic glasses. Int J Radiat Biol Relat Stud Phys Chem Med 1985 0.75
105 Sleep apnea in a senior population. Sleep 1982 0.75
106 Frequency and consequences of the "overlap-syndrome" (chronic obstructive pulmonary disease plus sleep apnoea). Monaldi Arch Chest Dis 1993 0.75
107 [Therapy of the sleep apnea syndrome]. Prax Klin Pneumol 1987 0.75
108 [A difficult baptism. Or does the upper airway resistance syndrome exist?]. Rev Mal Respir 2000 0.75
109 [Nycterohemeral variations in plasma growth hormone (GH) levels and sleep apnea syndromes: their relationship with obesity (author's transl)]. Rev Electroencephalogr Neurophysiol Clin 1982 0.75
110 . . . Such stuff as dreams are made. . . Sleep Med Rev 1999 0.75
111 [Sleep and COPD]. Rev Prat 1995 0.75
112 Effects of midazolam on sleep in normal subjects. Arzneimittelforschung 1983 0.75
113 [Sleep apnea syndrome. Effect of almitrine]. Presse Med 1983 0.75
114 Sleep medicine reviews. Sleep Med Rev 1997 0.75
115 [Value of sleep polygraph examination in the etiological diagnosis of apparently inexplicable respiratory insufficiency]. Bull Eur Physiopathol Respir 1985 0.75
116 [Pre- and post-apneic sleep in the Pickwickian patient]. Rev Electroencephalogr Neurophysiol Clin 1976 0.75
117 [Computed tomography in multiple trauma patients: technical aspects, work flow, and dose reduction]. Radiologe 2014 0.75
118 [Diagnosis of sleep apnea syndrome]. Rev Mal Respir 1990 0.75
119 [Sleep and nocturnal desaturation of patients with chronic obstructive bronchopneumopathies. Effects of almitrine bismesylate administered orally]. Rev Mal Respir 1985 0.75
120 Matrix isolation of free radicals from myo-inositol formed by H reaction in acidic glasses. Int J Radiat Biol Relat Stud Phys Chem Med 1983 0.75
121 [A difficult baptism. Where does the syndrome of upper airway resistance exist?]. Rev Mal Respir 1999 0.75
122 Prostatitis unplugged? Prostatic massage revisited. Tech Urol 1999 0.75
123 Sleep and breathing abnormalities in a case of Prader-Willi syndrome. The effects of acute continuous positive airway pressure treatment. Acta Paediatr Scand 1991 0.75
124 [Myoclonus in the adult: diagnostic approach]. Neurophysiol Clin 2001 0.75
125 [A device for mandibular advancement in respiratory disorders of sleep. Clinical study]. Orthod Fr 2000 0.75
126 [The treatment of sleep apnea syndromes (SAS)]. Prax Klin Pneumol 1988 0.75
127 Inter- and intrahemispheric processing of letter stimuli by dyslexic children and normal readers. Cortex 1986 0.75
128 [Sleep apnea syndromes]. Presse Med 1984 0.75
129 [Polygraphic study during hyperpnea tests in elderly subjects (author's transl)]. Rev Electroencephalogr Neurophysiol Clin 1981 0.75
130 Audit of ranitidine administration in parenteral nutrient solutions. Am J Hosp Pharm 1991 0.75
131 [Recording ventilation during sleep using pneumotachography: drawbacks and disadvantages]. Rev Electroencephalogr Neurophysiol Clin 1983 0.75
132 Treatment of obstructive sleep apnoea. Lancet 1984 0.75
133 Urinary tract infection in childhood. Curr Opin Urol 2001 0.75
134 [Direct fibroscopic observation of hypnic apnea in pickwickian subjects]. Nouv Presse Med 1976 0.75
135 The infernal cyclist. Sleep Med Rev 1999 0.75
136 [Study of the real situation of improvement by Zopiclone in treatment of insomnia among persons working during night shifts]. Rev Neurol (Paris) 2002 0.75
137 [Treatment of nocturnal hypoxia in chronic obstructive bronchopneumopathies]. Prax Klin Pneumol 1988 0.75
138 [Short-duration nocturnal hypoxemia and persistent pulmonary hypertension]. Rev Mal Respir 1998 0.75
139 Towards an identification of odorant receptors. J Recept Res 1993 0.75
140 [Hospital hygiene. New construction management requirements in the area of surgery and intensive care medicine]. Fortschr Med 1989 0.75
141 Drug therapy for obstructive sleep apneas. Am Rev Respir Dis 1984 0.75
142 [Apnea during the sleep of Pickwickian patients. Contribution of pneumotachography to their study]. Nouv Presse Med 1976 0.75
143 [Objective measurement of compliance during treatment of sleep apnea with continuous positive pressure]. Prax Klin Pneumol 1988 0.75
144 [Pharyngeal obstruction and the functional adaptation of the natural posture of the head and the hyoid bone in sleep apnea syndrome]. Orthod Fr 1992 0.75
145 Inter- and intrahemispheric processing of visual and auditory stimuli by dyslexic children and normal readers. Int J Neurosci 1985 0.75
146 Effect of continuous positive airway pressure treatment on the subsequent EEG spectral power and sleepiness over sustained wakefulness in patients with obstructive sleep apnea-hypopnea syndrome. Clin Neurophysiol 2011 0.75
147 [A multicenter trial of a device for treating obstructive sleep apnea by continuous positive pressure]. Bull Eur Physiopathol Respir 1986 0.75
148 [Is gastroesophageal reflux responsible for the episodes of nocturnal desaturation in chronic bronchitis patients?]. Presse Med 1988 0.75
149 [From sleep apnea syndrome to chronic respiratory insufficiency and right cardiac effects]. Rev Mal Respir 1990 0.75
150 [Morphologic peculiarities and major discriminants in patients with sleep apnea]. Orthod Fr 1988 0.75
151 In vitro evidence that immunuaffinity-purified MOG contains immunogenic quantities of contaminating mouse IgG; techniques for producing Ig-free MOG. J Neuroimmunol 2001 0.75
152 [The infernal machine]. Neurophysiol Clin 1998 0.75
153 Hemicholinum-3 binding sites in the nervous tissue of insects. Neurochem Int 1989 0.75
154 [Respiratory evaluations during sleep]. Rev Mal Respir 1986 0.75
155 [Electromyographic study of the pharyngo-laryngeal muscles in Pickwick's disease (author's transl)]. Ann Otolaryngol Chir Cervicofac 1981 0.75
156 [Toxic trigeminal disease and polyvinylidene chloride]. Rev Otoneuroophtalmol 1971 0.75
157 Sleep disordered breathing and pulmonary hypertension. Eur Respir J Suppl 1990 0.75
158 [Hypo-apneic sequences in pickwickian subjects. Apneic grouping and trains on apnea]. Rev Electroencephalogr Neurophysiol Clin 1976 0.75
159 [Excessive daytime sleepiness]. Rev Med Interne 1997 0.75
160 [Sleepiness and sleep apnea syndrome. Analysis of 188 questionnaires (102 patients and 86 controls)]. Neurophysiol Clin 1993 0.75
161 [Measures for the prevention of infections in anesthesia]. Klin Anasthesiol Intensivther 1990 0.75
162 [Neuro-ophthalmologic forms of Hodgkin's disease (apropos of a case)]. Rev Otoneuroophtalmol 1977 0.75
163 Cognitive components of event-related potentials in obstructive sleep apnea syndrome: a study of 47 patients prior and after nCPAP treatment. Acta Psychiatr Belg 1996 0.75
164 [Hypersomnia. Investigational strategy for evaluating hypersomnia]. Presse Med 1998 0.75
165 [Sleep apnea syndromes. Treatment with continuous positive pressure by the nasal route]. Presse Med 1984 0.75
166 Effect of piracetam on the single word and prose reading of dyslexic children. Psychopharmacol Bull 1984 0.75